2014
DOI: 10.2217/fon.14.148
|View full text |Cite
|
Sign up to set email alerts
|

Postoperative Radiotherapy with Volumetric Modulated Arc Therapy of Lacrimal Gland Carcinoma: Two Case Reports and Literature Review

Abstract: Postoperative VMAT for treatment of lacrimal gland tumors offers improved outcome, with manageable side effects. In the context of photon beam radiotherapy, VMAT emerged as a valuable treatment option for these malignant tumors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
2
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 26 publications
1
2
0
Order By: Relevance
“…PTV contained this clinical target volume with a margin of 5 mm. Anatomically, the lacrimal fossa, lateral and superior portions of the orbita were included, consistent with the literature [6]. The PTV resembled an ellipsoid figure expanding into the eyeball and including the left optical nerve .…”
supporting
confidence: 52%
See 1 more Smart Citation
“…PTV contained this clinical target volume with a margin of 5 mm. Anatomically, the lacrimal fossa, lateral and superior portions of the orbita were included, consistent with the literature [6]. The PTV resembled an ellipsoid figure expanding into the eyeball and including the left optical nerve .…”
supporting
confidence: 52%
“…In the literature, good visual capacities could be preserved in the majority of patients (68%-91%) [3,8,15], but attention should be paid to keratitis, a serious side effect in 24% of patients in the Esmaeli study, which can lead to blindness [10]. Consequently, some authors discuss the delineation of detailed intraorbital structures as retina or sclera for toxicity evaluation [6]. It has to be kept in mind that visual impairment or blindness is a real danger of the malignancy itself, about which the patient has to be counseled.…”
Section: As Tumor Control Increases Toxicity Attracts Attentionmentioning
confidence: 99%
“…Very few reports in the literature specifically relates to the use of IMRT or VMAT in LGACC. A case reported by Orlandi et al [ 20 ] presented favorable outcomes in two patients with lacrimal gland cancer treated by postoperative VMAT, with no evidence of disease at 18-month follow-up. To the best of our knowledge, this is the second report describing the use of postoperative VMAT in the management of lacrimal gland malignancies.…”
Section: Discussionmentioning
confidence: 99%